跳至主要内容
临床试验/NCT03005353
NCT03005353已完成2 期

Randomized Clinical Trial for Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.

Assiut University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
100
试验地点
1
主要终点
The percentage of patients with complete cure

研究概览

简要总结

Fungal infections have increased over the last two decades, largely because of the increasing size of the population at risk, including patients who are immunocompromised, broad-spectrum antibiotics and intravascular catheter users. Essential oils and other extracts of plants have evoked interest as sources of natural products. They have been shown to possess antibacterial, antifungal, antiviral, insecticidal and antioxidant properties. To the best of our knowledge, no study has examined the efficacy of cumin seed extract on relieving vulvovaginal candidiasis in vivo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women were 18-49 years old and were married;
  • They had not used antibiotics, immunosuppressive drugs, or vaginal drugs 14 days before the study;
  • They did not suffer from trichomonal vaginitis, bacterial vaginitis, or cervicitis based on direct smear;
  • Candidiasis culture was in agreement with clinical symptoms and patient's complaints.

排除标准

  • Pregnant and lactating women;
  • Those who had abnormal uterine bleeding;
  • Women with diabetes or autoimmune diseases;
  • Women refuse to participate in the study.

研究组 & 干预措施

Cumin seed extract

Experimental

Group A (study group) will receive Cumin seed extract vaginal suppositories once daily for 7 days.

干预措施: Cumin seed extract (Drug)

clotrimazole

Active Comparator

Group B will receive conventional clotrimazole vaginal suppositories once daily for 7 days.

干预措施: clotrimazole (Drug)

结局指标

主要结局

The percentage of patients with complete cure

时间窗: one week

cure is defines as absence of symptoms

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Abbas

Dr

Assiut University

研究点 (1)

Loading locations...

相似试验